MedPath
TGA Approval

DOSTINEX cabergoline 0.5mg tablet bottle (52158)

52158

DOSTINEX cabergoline 0.5mg tablet bottle

Pfizer Australia Pty Ltd

April 21, 1995

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/3c9a15ef28a3f6e74c2fd679c153743f.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/b731aa521a0374eda50d73c4b4186aa4.pdf

Active Ingredients

cabergoline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.